AbbVie Inc. (ABBV) › Operating IncomeAbbVie Inc. (ABBV) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: $3.62B2012: $5.82B2013: $5.66B2014: $3.41B2015: $7.54B2016: $9.34B2017: $9.54B2018: $6.38B2019: $12.98B2020: $11.36B2021: $17.92B2022: $18.12B2023: $12.76B2024: $9.14B2025: $15.07B$15.07B2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$15.07B+65.0%2024$9.14B-28.4%2023$12.76B-29.6%2022$18.12B+1.1%2021$17.92B+57.7%2020$11.36B-12.5%2019$12.98B+103.4%2018$6.38B-33.1%2017$9.54B+2.2%2016$9.34B+23.9%2015$7.54B+121.0%2014$3.41B-39.8%2013$5.66B-2.6%2012$5.82B+60.7%2011$3.62B—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share